Unraveling The Complexity Of Tech Transfer
Source: Rockwell Automation
By Sachin Misra, Principal, Kalypso, A Rockwell Automation Company

COVID-19 showed the life science industry that fast tech transfers are possible, but there is also recognition that the type of manpower the industry dedicated to driving the tech transfer for the COVID-19 vaccine is not sustainable. Now, pathways are being explored to improve tech transfer on a commercial product level. Learn more about the complexities of tech transfer, scaling-up, what's missing to improve tech transfer process times, and the two-pathway approach you can take when adopting digital native tools.
access the Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.
Subscribe to Pharmaceutical Online
X
Subscribe to Pharmaceutical Online
Rockwell Automation
This website uses cookies to ensure you get the best experience on our website. Learn more